/Bristol-Myers%20Squibb%20Co_%20logo%20on%20phone%20by-%20Piotr%20Swat%20via%20Shutterstock.jpg)
Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. With a market cap of $120.9 billion, the company offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. BMY is expected to release its Q1 2026 earnings on Thursday, Apr. 30, before the market opens.
Ahead of the event, analysts expect the company’s EPS to be $1.46 on a diluted basis, down 18.9% from $1.80 in the year-ago quarter. The company has exceeded Wall Street’s EPS estimates in each of its last four quarters.